Innovative additive reduces charge recombination and heals interfaces in CsPbI3 solar cells, improving stability and efficiency.
The charge recombination resulting from the numerous perovskite defects and the inferior buried interface remarkably deteriorates the performance of inorganic perovskite solar cells. Here, we introduce 4-aminobenzenesulfonic acid (ABSA) into the CsPbI3 perovskite precursor to simultaneously reduce perovskite defects through modulating CsPbI3 perovskite crystallization and heal the buried interface through in situ forming a ABSA dipolar interlayer. The interaction of the ABSA molecule with CsPbI3 precursor components hinders CsPbI3 perovskite crystallization, resulting in forming a compact and smooth CsPbI3 perovskite film with reduced defects and enhanced crystallinity. Meanwhile, ABSA molecules are excluded from the CsPbI3 perovskite crystal and pushed downward during the perovskite crystallization process. Consequently, ABSA molecules accumulate at the bottom surface of the CsPbI3 perovskite and in situ form an ABSA dipolar interlayer, which effectively heals the buried interface and promotes interfacial charge transfer. As a consequence, the planar carbon-based CsPbI3 cell with the ABSA additive demonstrates a largely improved performance with a power conversion efficiency up to 17.89%. In particular, the unencapsulated CsPbI3 cell maintains over 90% of the original efficiency in ambient air after 480 h of storage, indicating superior long-term stability.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: